Overcoming the Limitations of Conventional Cell Engineering

Daniel Levine

Principal at Levine Media Group

发布日期: 2021年7月9日

DNA-modified cells can behave unpredictably in the body and there is a risk that they could proliferate uncontrolled, cause severe toxicities, and even survive unchecked for months or years. Cartesian uses its platform technology to engineer RNA into cells, making time-controlled changes. The company is developing treatments for cancer, respiratory conditions, and autoimmune diseases such as myasthenia gravis. We spoke to Murat Kalayoglu, president and CEO of Cartesian, about its RNA-engineered cell therapies, how they work and how the company is pushing the use of cell therapies beyond cancer.

要查看或添加评论，请登录

Cell Therapies for Solid Tumors, Scaling N-of-1 Therapies, and Going Where Antibody Therapies Can't with AI

2024年11月1日
Damage Control, N-of-1 Therapies, and Introducing MitoCast

2024年10月1日
The Promise and Peril of CRISPR, Drug Developing Patients, and Going Deep with AI

2024年9月2日
The Next Blockbuster within You, Treatments for Nonsense, and Better Decision-Making through AI

2024年8月1日
AI, Real-World Data, and Regenerative Medicine

2024年7月1日
Immunotherapies, Genetic Medicines, and Patient Advocates Reinventing Drug Development

2024年6月3日
TIL Therapies, Transomics, and Questions of Value

2024年4月29日
Why a Topical Cannabidiol Gel May Help Treat the Behavioral Symptoms of Fragile X

2023年2月3日
A Company Where It takes Guts and Brains to Develop Drugs

2023年2月2日
An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty

2023年1月27日

查看全部

社区洞察

Data Mining

How can you ensure that your cancer diagnosis is accurate?
Materials Science

What are the benefits of engineering bone marrow with scaffolds?
Bioengineering

What are the limitations of molecular imaging in detecting early-stage cancer?
Case Management

What does a hematologist do?
Translational Research

How do you keep up with the latest advances and trends in biomarker translational research in oncology?
Artificial Intelligence

How can AI personalize cancer treatment plans?
Biotechnology

How can you ensure the safety of cell-based therapies?
Bioengineering

How can image reconstruction techniques help doctors diagnose cancer more accurately?
Bioengineering

How can imaging biomarkers predict the risk of developing a disease?
Patient Advocacy

How can you help patients understand cancer screening guidelines?

Cell Therapies for Solid Tumors, Scaling N-of-1 Therapies, and Going Where Antibody Therapies Can't with AI

2024年11月1日

Damage Control, N-of-1 Therapies, and Introducing MitoCast

2024年10月1日

The Promise and Peril of CRISPR, Drug Developing Patients, and Going Deep with AI

2024年9月2日

The Next Blockbuster within You, Treatments for Nonsense, and Better Decision-Making through AI

2024年8月1日

AI, Real-World Data, and Regenerative Medicine

2024年7月1日

Immunotherapies, Genetic Medicines, and Patient Advocates Reinventing Drug Development

2024年6月3日

TIL Therapies, Transomics, and Questions of Value

2024年4月29日

Why a Topical Cannabidiol Gel May Help Treat the Behavioral Symptoms of Fragile X

2023年2月3日

A Company Where It takes Guts and Brains to Develop Drugs

2023年2月2日

An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty

2023年1月27日

社区洞察